AmzDoge Financial landed on the NASDAQ screen in Times 27-01-2023, 11:11

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Encore Data Products Offers Fluent Front Office 16-02-2023, 05:14